Title
2019 CEoT Program
For more information on the STAR 2019 Meeting, please click here.
Thursday, February 21, 2019
12:30 PM
Welcome Remarks
Anil Chandraker, MD, FASN, FAST, FRCP
Kenneth Newell, MD, PhD, FAST
12:45 – 2:00 PM
Satellite Lunch Symposium Presented by One Lambda Inc., A Thermo Fischer Scientific Brand†
This is not an official function of the CEoT meeting and is not endorsed by the AST.
2:00 PM – 3:30 PM
Session 1: Personalized Medicine – How Do We Catch Up? *
Moderators: Michelle Josephson, MD
Kenneth Newell, MD, PhD, FAST
2:00 PM The Role of the Intestinal Microbiome in Allogeneic Hematopoietic Cell Transplantation
Marcel van den Brink, MD, PhD
2:20 PM Use of Genetic Information to Direct Personalized Care of Individuals with Cardiovascular Disease
Elizabeth McNally, MD, PhD
Allan Kirk, MD, PhD, FACS
3:00 PM Dicussion
Break
4:00 PM – 5:30 PM
Session 2: Shark Tank: George Lucas Foresees the Future of Transplantation – All Things Omics
Moderators: Kenneth Newell, MD, PhD, FAST
Roslyn Mannon, MD, FASN, FAST
4:00 PM The Force is in the Blood
Minnie Sarwal, MD, MRCP, FRCP, DCH, PhD
4:20 PM The Force is in the Urine
Peter Heeger, MD
4:40 PM The Force is in the cf DNA
Roy Bloom, MD
5:00 PM The Force is in the Tissue
Michael Mengel, MD
5:20 PM Discussion
5:45 PM – 7:30 PM
Poster Walk & Reception
Friday, February 22, 2019
7:30 AM – 10:15 AM
Session 3: Select One of Three Sessions
Option 1
Personalized Organ Allocation - The Right Organ, For the Right Recipient, at the Right Time*
Moderators: Richard Formica, MD
Jon Friedman, MD, FAST
When the Clock is Ticking
7:30 AM Brevity Matching for Kidney Transplant
Richard Formica, MD
7:45 AM Who Can Tolerate a Marginal Donor Graft?
David Foley, MD, FACS
8:00 AM Expedited/Batch Allocation for Kidney
John Friedewald, MD, FAST
8:15 AM Expedited/Batch Allocation for Liver
David Foley, MD, FACS
Only If You Have a Living Donor
8:45 AM Who is the Optimal Recipient for a Living Donor Liver Transplant?
Giuliano Testa, MD, MBA, FACS
9:00 AM Which Recipients Should Only Receive a Living Donor Kidney Transplant?
John Gill, MD, MS
Organ Transplantation Is Not Appropriate for You
9:15 AM Who Will Not Benefit from a Kidney Transplant?
Dierdre Sawinski, MD, FAST
9:30 AM Who Will Not Benefit from Liver Transplantation?
Kim Brown, MD
9:45 AM Discussion
Option 2
Heart Track: To Infinity and Beyond - Moving Past the Biopsy in Heart Transplantation*
Moderators: Jon Kobashigawa, MD
MaryJane Farr, MD
8:15 AM Donor Derived Cell Free DNA - Has the Answer Been There All Along?
Kiran Khush, MD
8:35 AM Epigenetics - Does miRNA Ask the Right Questions?
Palak Shah, MD, MS
Geetha Bhat, MD, PhD, FACC, FAST, FHFSA
9:15 AM Measuring Immunoresponsiveness - What Tools Do We Have in Our Arsenal?
Shelley Hall, MD
9:35 AM Molecular Signals of Intragraft Rejection: Is INTERHEART true NORTH?
Phillip Halloran, MD, PhD
9:55 AM Discussion
Option 3
Lung Track: Who's Monitoring the Monitor in Lung Transplantation Rejection Surveillance? *
Moderators: Sangeeta Bhorade, MD
Marty Zamora, MD
8:15 AM Donor Derived Cell Free DNA - Has the Answer Been There All Along?
Mark Nicolls, MD
8:35 AM Molecular Signals of Intragraft Rejection - Is INTERLUNG the Answer?
Phillip Halloran, MD, PhD
8:55 AM Epigenetics - Does miRNA Ask the Right Questions?
Thalachallour Mohanakumar, PhD
9:15 AM Gene Expression Profiling - Advantages and Disadvantages of Monitoring Risk Rather Than Injury
Sangeeta Bhorade, MD
9:35 AM Measuring Immunoresponsiveness - What Tools Do We Have in Our Arsenal?
Jeffrey Edelman, MD
9:55 AM Discussion
10:30 AM – 12:30 PM
Session 4: Select One of Three Sessions
Option 1
With all Our Drugs Why Can’t We Develop Evidence-Based, Individualized Immunosuppression? *
Moderators: John Gill, MD, MS
Andrew Adams, MD, PhD
10:30 AM Precision Medicine and Not Individualized Therapy is Required for Successful Novel Drug Development
Flavio Vincenti, MD
10:50 AM Belatacept - A Lesson in Personalized Immunosuppression
Andrew Adams, MD, PhD
11:10 AM Biomarkers to Assess Risk and Guide Immunosuppression in Kidney Transplantation
Peter Heeger, MD
11:30 AM Biomarkers of Rejection and Tolerance in Liver Transplantation
Josh Levitsky, MD, MS
11:50 AM Panel Discussion
Option 2
Heart Track: Customized Immunosuppression - Why Didn't I Think of That? *
Moderators: Shelley Hall, MD
Geetha Bhat, MD, PhD, FACC, FAST, FHFSA
10:30 AM To Treat or Not to Treat - What Induction Therapy is Beneficial?
David Nelson, MD
10:50 AM Circulating Antibodies - What, When, Why to Use Desensitization Therapy?
Jignesh Patel, MD, PhD
11:10 AM Using Genomics to Guide Immunosuppression Therapy
David Baran, MD
11:30 AM Cardiac iBox to Assess Rejection Risk and Customized Immunosuppression
Alexandre Loupy, MD, PhD
11:50 AM Immune Approach to Primary Graft Dysfunction
Barry Fine, MD, PhD
12:10 PM Discussion
Option 3
Lung Track: Individualizing Immunosuppression - Will We Get There in Lung Transplantation?*
Moderators: Marie Budev, DO, MPH
Daniel Dilling, MD
10:30 AM To Treat or Not to Treat - Which Patients May Benefit from Induction Therapy?
Ramsey Hachem, MD
10:50 AM Renal Sparing Protocols - Minimizing Risk and Maximizing Benefit in Individual Patients
Marie Budev, DO, MPH
11:10 AM Early CNI-Free Strategies and/or Eliminating the Antimetabolite - Balancing Safety and Efficacy
Cynthia Gries, MD, MSc
11:30 AM Donor Specific Antibodies - Different (Immunosuppressive) Strokes for Different Folks
Deborah Jo Levine, MD
11:50 AM Immune Approach to Primary Graft Dysfunction
Ankit Bharat, MD
12:10 PM Discussion
Break
12:45 PM – 2:00 PM
Satellite Lunch Symposium Presented by CareDx, Inc. †
This is not an official function of the CEoT meeting and is not endorsed by the AST.
2:00 PM – 2:30 PM
AST Innovation Award Presentation
Dianne McKay, MD
2:30 PM – 4:00 PM
Session 5: Personalized Aftercare – Can It Be That Hard? *
Moderators: Roy Bloom, MD
Michelle Josephson, MD
2:30 PM From Many to One - Applying Big Data to the Individual Patient in Front of You
Titte Srinivas, MD
2:50 PM Is the ibox as Good as a Crystal Ball or Better?
Alexandre Loupy, MD, PhD
3:10 PM What Does Personalized Care Mean to Patients?
Ulf Meier-Kriesche, MD, FAST
3:30 PM Discussion
4:00 PM – 5:30 PM
Session 6: Persobalized Strategies to Improve Access and Outcomes in Patients of African Ancestry and Other Populations at Risk for a Poor Outcome*
Moderator: Neil Powe, MD, MPH, MBA
J. Keith Melancon, MD
4:00 PM Social Factors and Access to Transplantation in Populations at Risk for a Poor Outcome
Jesse Schold, PhD, M. Stat, M. Ed
4:15 PM Biological Basis for Increased Risk of Graft Loss in AA - APOL1 and Beyond
Jonah Odim, MBA, MD, PhD
4:30 PM Use of Contemporary Technologies to Improve At-Risk Candidate and Recipient Engagement
Elisa Gordon, PhD, MPH
4:45 PM Liver Transplant Access in Underserved Populations - Opportunity for Targeted Interventions
Juan Carlos Caicedo, MD
5:00 PM Taking House Calls to a New Level - Applying Telemedicine in Transplantation
Marina Serper, MD, MS
5:15 PM Discussion
Saturday, February 23
7:00 AM – 8:15 AM
Breakfast Symposium Presented by CSL Behring †
This is not an official function of the CEoT meeting and is not endorsed by the AST.
Break
8:30 AM – 10:30 AM
Session 7: Select One of Two sessions
Option 1
Back to the Future – Beginning with HLA to Personalize Care*
Moderator: Anat Tambur, DMD, PhD
Mandy Ford, PhD, FAST
8:30 AM HLA Antibody Complement Based Assays
Howard Gebel, PhD, D(ABHI)
Robert Bray, PhD
8:50 AM HLA Antibody Attributes
Nicole Valenzuela, PhD, D(ABHI)
9:10 AM Discussion
9:30 AM HLA Molecular Mismatch Assessment
Peter Nickerson, MD, FRCPC
9:50 AM Discussion
10:00 AM Risk Assessment for Alloimmune Memory – Beyond Antibodies
Mandy Ford, PhD, FAST
10:20 AM Discussion
Option 2
Thoracic Cases: Applying Personalized Medicine in the Real World of Thoracic Transplantation
Moderators: Sangeeta Bhorade, MD
Kevin Shah, MD
8:30 AM Treatment of the Sensitized Heart Patient Pre-Transplant - What's the Right Thing?
Jignesh Patel, MD, PhD
Kevin Shah, MD
8:50 AM Donor Specific Antibodies after Lung Transplantation
Ramsey Hachem, MD
Amit Bery, MD
9:10 AM CNI-Free Immunosuppression
Kiran Khush, MD
Yas Moayedi, MD
9:30 AM Primary Graft Dysfunction and Autoantibodies in Lung Transplantation
Ankit Bharat, MD
Chitaru Krihara, MD
9:50 AM PGD in a Heart Transplant Recipient
MaryJane Farr, MD
Kevin Clerkin, MD
10:10 AM Discussion
Break
10:45 AM – 11:45 AM
Keynote†
Matthew Albert, MD, PhD, ScB
Principal Scientist, Cancer Immunology, Genentech
Break to Get Lunch
12:00 PM – 1:30 PM
Session 8: Transplant Center Practice – Is Variety the Spice of Life? *
Moderators: John Gill, MD, MS
Nicole Turgeon, MD
12:00 PM Variability in Center Level Acceptance of Complex Patients
Jesse Schold, PhD, M. Stat, M. Ed
12:30 PM The Centers of Excellence Model – Do They Work and How to Make Them Work
Julio Montaner, MD
1:00 PM Discussion
1:30 PM – 3:30 PM
Session 9: Trailblazers - Programs with Specialized Programs of Patient Care*
Moderator: Emily Blumberg, MD, FAST
1:30 PM Transplantation of Patients with Kidney Failure and Diabetes
Dixon Kaufman, MD, PhD
2:00 PM Bariatric Surgery for Morbid and Super Obese Transplant Candidates
Julie Heimbach, MD
2:30 PM Desensitization to Increase Access for Highly Sensitized Patients
Stanley Jordan, MD, FASN, FAST
3:00 PM Discussion
3:30 PM
Summary Heart/Lung Track
Jon Kobashigawa, MD
Sangeeta Bhorade, MD
3:45 PM
Summary of Meeting/Closing
Anil Chandraker, MD, FASN, FAST, FRCP
Kenneth Newell, MD, PhD, FAST
5:00 PM
Closing Reception